Comparison of the Effectiveness of Vedolizumab and Ustekinumab in Crohn's Disease Patients Who Failed Anti-tumor Necrosis Factor-α Treatment in Japan: An Observational Study Utilizing Claims Database
PMID: 38369343
Source: Biol Pharm Bull
Publication date:
2025-07-24
Year:
2024
Abstract
NULL